雜志介紹

Journal Of Neuroimmune Pharmacology雜志介紹

《Journal Of Neuroimmune Pharmacology》是一本以English為主的未開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱(chēng)神經(jīng)免疫藥理學(xué)雜志，本刊主要出版、報(bào)道醫(yī)學(xué)-NEUROSCIENCES領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專(zhuān)業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專(zhuān)業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為5.2，最新CiteScore 指數(shù)為13.6。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Protective Effects of 1-Methylnicotinamide on Aβ<Subscript>1–42</Subscript>-Induced Cognitive Deficits, Neuroinflammation and Apoptosis in Mice

  Author: Lili Fu, Caihong Liu, Liang Chen, Yangge Lv, Guoliang Meng, Mei Hu, Yan Long, Hao Hong, Susu Tang

• Curcumin Ameliorates the Neurodegenerative Pathology in A53T α-synuclein Cell Model of Parkinson’s Disease Through the Downregulation of mTOR/p70S6K Signaling and the Recovery of Macroautophagy

  Author: Tian-Fang Jiang, Ying-Jie Zhang, Hai-Yan Zhou, Hong-Mei Wang, Li-Peng Tian, Jun Liu, Jian-Qing Ding, Sheng-Di Chen

• SIV Infection Impairs the Central Nervous System in Chinese Rhesus Macaques

  Author: Hang Liu, Qian-Hao Xiao, Jin-Biao Liu, Jie-Liang Li, Li Zhou, Qiao-Yang Xian, Yong Wang, Jing Zhang, Xu Wang, Wen-Zhe Ho, Ke Zhuang

• Meta-Analysis of the <Emphasis Type="Italic">COMT</Emphasis> Val158Met Polymorphism in Major Depressive Disorder: Effect of Ethnicity

  Author: Maiqiu Wang, Yunlong Ma, Wenji Yuan, Kunkai Su, Ming D. Li

英文介紹

Journal Of Neuroimmune Pharmacology雜志英文介紹

The aims of the Journal of Neuroimmune Pharmacology are to promote the dissemination, interest, and exchange of new and important discoveries for the pharmacology and immunology of the nervous system. The aims parallel that of the Society on NeuroImmune Pharmacology by increasing the fundamental understanding of neurologic and neuropsychiatric disorders affected by the immune system or vice versa and towards pharmacologic measures that lead, either to a better understanding of disease mechanisms, or by improving disease outcomes. The scope of JNIP includes all primary works and reviews into the etiology, prevention, and treatment of neuroimmune and nervous system diseases affected by disordered immunity. Original studies serving to define neuroimmune modulation of environmental or endogenous cues such as toxins and drugs of abuse, hormones, and cytokines are welcome. JNIP will serve as a reliable source of interdisciplinary information bridging the fields of pharmacology, immunology, and neuroscience.